Colgate-Palmolive (NYSE:CL) Price Target Raised to $99.00

Colgate-Palmolive (NYSE:CLFree Report) had its target price boosted by JPMorgan Chase & Co. from $97.00 to $99.00 in a research report report published on Friday morning,Benzinga reports. They currently have an overweight rating on the stock.

Several other research firms also recently issued reports on CL. Morgan Stanley dropped their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. Stifel Nicolaus lowered their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Finally, Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $101.72.

Read Our Latest Analysis on CL

Colgate-Palmolive Trading Down 0.8 %

Colgate-Palmolive stock opened at $89.80 on Friday. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The firm has a market capitalization of $72.87 billion, a PE ratio of 25.51, a PEG ratio of 4.20 and a beta of 0.40. The business’s 50-day simple moving average is $89.02 and its 200-day simple moving average is $94.67.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in CL. Axxcess Wealth Management LLC raised its stake in shares of Colgate-Palmolive by 0.3% during the 4th quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock valued at $3,526,000 after purchasing an additional 117 shares during the period. Commonwealth Financial Services LLC increased its position in shares of Colgate-Palmolive by 4.5% during the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after buying an additional 118 shares during the period. Wescott Financial Advisory Group LLC lifted its holdings in shares of Colgate-Palmolive by 3.5% in the fourth quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company’s stock worth $320,000 after buying an additional 119 shares in the last quarter. D Orazio & Associates Inc. boosted its holdings in Colgate-Palmolive by 4.2% in the 4th quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company’s stock valued at $271,000 after purchasing an additional 120 shares during the period. Finally, Lantz Financial LLC grew its position in Colgate-Palmolive by 0.6% during the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock worth $1,831,000 after buying an additional 122 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.